THE BALANCE

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Abdullah Boulad, Founder & CEO

Prefer to speak with our founder?

Abdullah Boulad · Founder & CEO

Private treatment

Private Marijuana (Cannabis) Addiction Treatment & Rehab

Private marijuana and cannabis treatment with coordinated assessment of sleep, anxiety, mood, medication, pain, and other co-occurring needs.

Clinically reviewed byDr. Sarah Boss, MD
Stone residence with a lawn and swimming pool

Quick Summary

  • Cannabis use disorder is assessed through impaired control, withdrawal, craving, and significant consequences rather than frequency, legality, or medical authorization alone.
  • Personalized treatment may combine psychological and behavioral therapies, medical review, co-occurring condition care, harm reduction, and practical relapse-prevention planning.
  • THE BALANCE offers one-client residential treatment in Mallorca or Zurich, while acute psychosis, immediate suicide risk, or medical instability requires urgent local care.
Cannabis Use Disorder | Treatment guide

Your guide to care

Cannabis Use Disorder treatment guide

A clear overview of assessment, treatment and what to expect at THE BALANCE. Read it in your own time or share it with someone close to you.

PDF · 8 pages · English · 257 KB

Marijuana and Cannabis Addiction Treatment Overview

THE BALANCE offers private marijuana and cannabis addiction treatment in Zurich, Switzerland, and Mallorca, Spain. Suitable residential programs combine a luxury private residence with an individual plan dedicated to one admitted client.

You may seek help with cannabis while anxiety, depression, trauma, attention, sleep, pain, or another substance also needs attention. The assessment considers the whole situation rather than assuming that frequency of use, legal status, or medical authorization alone establishes a disorder.

Cannabis Use and Co-Occurring Needs

THE BALANCE reviews control over use, consequences, symptoms, prescribed treatment, physical health, and previous care together. Relevant psychological, psychiatric, medical, and practical input forms one coordinated plan.

Sleep, emotional health, and the situations associated with use can be addressed alongside addiction-specific work. Existing clinicians can contribute with appropriate authorization. Priorities are reviewed as the relationship between symptoms and substance use becomes clearer.

Luxury Private Rehab With an Individual Purpose

Private living and a personally organized schedule provide space for treatment, rest, and practical change. The one-client model is not a promise of effortless abstinence or a detox holiday. Treatment remains connected to the routines and support needed after the stay.

Multiple concerns or earlier unsuccessful care do not automatically exclude admission. Current risks, available expertise, and the appropriate level of support determine suitability. Acute psychiatric or medical needs may require a different setting. The residence, services, and continuing care are confirmed individually.

Cannabis is used recreationally, socially, and medically, and many people do not develop a disorder. For others, use becomes difficult to control and continues despite effects on motivation, memory, sleep, anxiety, mood, relationships, work, or physical health. High-potency products, concentrates, frequent use, and use during adolescence may carry different risks from occasional lower-potency adult use.

THE BALANCE provides private assessment and treatment for selected adults with cannabis use disorder. Treatment begins by understanding the actual pattern, the reasons for use, the presence of withdrawal, and whether anxiety, psychosis, depression, trauma, ADHD symptoms, pain, insomnia, or another condition is involved.

When Cannabis Use Becomes a Disorder

Cannabis use disorder is considered when there is impaired control, craving, unsuccessful attempts to reduce use, increasing time devoted to use or recovery, tolerance, withdrawal, and continued use despite significant harm. Frequency matters, but it does not determine the diagnosis by itself.

A person may use cannabis every evening to sleep, intermittently during periods of stress, or intensively through high-potency products. Assessment looks at function and consequences rather than making assumptions based solely on legality, social acceptance, or a medical authorization.

Products, Potency, and Route of Use

Cannabis products vary substantially in THC and cannabidiol content, dose, route, duration, and reliability. Smoked flower, vaping products, concentrates, edible products, and prescribed formulations can produce different effects and risks.

The team asks what is used, how much, how often, where it comes from, and what is combined with it. Product labels may be inaccurate, and unregulated supplies can contain contaminants or unexpected substances.

Withdrawal and Early Abstinence

People who use cannabis frequently may experience irritability, anxiety, sleep disturbance, vivid dreams, reduced appetite, low mood, restlessness, or craving after stopping. Symptoms can make a person believe that cannabis is the only thing that allows them to sleep or function.

Withdrawal is generally approached differently from alcohol or benzodiazepine withdrawal, but clinical review is still important when symptoms are severe, when other substances are involved, or when the person has significant psychiatric or medical conditions.

Cannabis, Anxiety, and Panic

Some people use cannabis to reduce anxiety, while others experience panic, racing thoughts, derealization, or increased fear after use. The relationship can change with potency, dose, setting, sleep, and individual vulnerability.

Assessment considers whether anxiety predates use, appears only during intoxication or withdrawal, or has become an independent condition. Treatment should address the anxiety itself rather than simply telling the client to stop using cannabis.

Psychosis, Paranoia, and Acute Confusion

Cannabis use can be associated with paranoia, hallucinations, disorganized thinking, or psychosis, particularly with frequent or high-potency exposure and in susceptible individuals. A first episode of psychosis requires prompt psychiatric assessment.

Acute psychosis, severe agitation, dangerous behavior, inability to care for basic needs, or the need for involuntary or secure care is not appropriate for a private residential admission. Hospital or early-intervention services may be necessary.

Sleep and Cannabis Use

Cannabis may initially make it easier to fall asleep, yet regular use can become part of a cycle involving tolerance, daytime effects, and rebound sleep disturbance during withdrawal. Other sleep conditions, including insomnia, circadian disruption, sleep apnea, anxiety, pain, or medication effects, may remain untreated.

The plan may include behavioral sleep treatment, medical review, changes to daily routine, and treatment of co-occurring psychiatric concerns. Sleep should not be reduced to a reason either to continue or prohibit cannabis without assessment.

Prescribed or Medically Authorized Cannabis

A medical prescription or authorization does not eliminate the possibility of dependence, side effects, or problematic use. At the same time, treatment should not dismiss a legitimate medical indication or make medication changes without involving the responsible prescriber.

The team reviews the indication, product, dose, benefit, side effects, alternatives, and the client’s goals. Pain, neurological illness, or another physical condition may require independent specialist input.

Assessment of Co-Occurring Conditions

Assessment and Treatment Planning considers depression, anxiety, trauma, ADHD symptoms, bipolar-spectrum illness, psychosis risk, eating patterns, pain, and other substance use. Cannabis can temporarily alter sleep, motivation, memory, mood, and perception, complicating diagnosis.

The team may need time to observe symptoms without intoxication before drawing firm conclusions. This should not delay urgent treatment when risk is present.

Psychological and Behavioral Treatment

Treatment may include motivational approaches, cognitive behavioral therapy, contingency management, relapse-prevention work, and treatment of co-occurring conditions. The plan considers triggers, access, social context, beliefs about benefit, boredom, stress, identity, and what cannabis has come to regulate.

Private Marijuana (Cannabis) Addiction Treatment & Rehab

Care built around you.

Different areas of support. One coordinated plan.

You

Your needs, history and goals

Psychological care

Work with triggers, coping and patterns that maintain use.

Clinical care

Assess withdrawal risk, physical health and prescribed medication.

Daily foundations

Rebuild routines and practical support around the treatment plan.

Continuing care

Planning for ongoing support and the transition home.

No single therapy is appropriate for everyone. The objective is to build alternatives that remain realistic after discharge, not simply to remove cannabis during a protected stay.

Medication

There is no universal medication approved to resolve cannabis use disorder. A psychiatrist or physician may treat specific withdrawal symptoms or co-occurring conditions when appropriate, with attention to interactions, misuse risk, and the available evidence.

Medication should not be presented as a substitute for psychological and environmental change. It also should not be withheld automatically from someone who has a substance-use history.

Family, Work, and Social Environment

Family members may disagree about whether cannabis is the problem. One person may see it as harmless or therapeutic, while another observes withdrawal, secrecy, reduced functioning, or repeated conflict. Treatment can separate moral debate from observable behavior and agreed goals.

Workplace, travel, driving, legal, and professional consequences vary by jurisdiction. THE BALANCE does not provide legal advice, and a client should not assume that legality at home applies while traveling internationally.

One-Client Residential Treatment

Residential treatment in Mallorca or Zurich is dedicated to one client. This can provide distance from access and habitual environments while allowing sleep, mood, anxiety, cognition, physical health, and engagement to be observed over time.

Privacy may support honest disclosure, but the clinical standard remains the same for every client. The program is not a luxury detox holiday and does not guarantee abstinence or a particular outcome.

Continuing Care and Relapse Prevention

The continuing-care plan identifies triggers, social settings, products, travel, sleep, pain, psychiatric symptoms, and what the client will do if craving or use returns. It may involve local therapy, psychiatry, addiction care, family work, recovery support, or monitoring.

Where prescribed cannabis was involved, the relevant prescriber and medical indication need a clear handover. Cross-border availability and legality must be checked independently.

Suitability and Acute-Care Boundaries

Acute psychosis, severe confusion, dangerous behavior, immediate suicide risk, major intoxication, or medical instability requires urgent local assessment. A private residence is not a secure psychiatric unit or emergency department.

Admission depends on voluntary participation, psychiatric stability, polysubstance use, travel fitness, medical needs, and the availability of appropriate external pathways. See Suitability and Entry Criteria.

Mallorca, Zurich, and London

Residential treatment takes place in Mallorca or Zurich, one client per residence and program. The choice depends on clinical and practical needs.

London may support selected assessment, preparation, transition, and continuing care. It is not a residential cannabis treatment service.

Motivation, Attention, and Cognitive Concerns

Some clients report reduced initiative, short-term memory difficulty, slower thinking, or diminished follow-through. These experiences may be related to cannabis, sleep, depression, anxiety, ADHD, medication, or another condition. Assessment avoids assigning every cognitive complaint to cannabis without evidence.

Observation during a period without intoxication can clarify what improves and what persists. Where cognitive change is marked, new, or progressive, independent medical or neurological assessment may be required.

Readiness to Change and Harm Reduction

Not every person is ready to commit to long-term abstinence at first contact. Motivational work can explore perceived benefits, concerns, previous attempts to change, and the client’s own goals without minimizing risk.

Where abstinence is not initially accepted, the clinical team may still address driving, high-potency products, mixing substances, psychosis risk, work safety, and use around vulnerable people. Harm reduction is not a claim that continued use is safe; it is a practical step within an evolving treatment process.

Onset During Adolescence and Adult Treatment

Although THE BALANCE’s page concerns adult treatment, the history may begin in adolescence. Earlier onset can influence education, relationships, emotional development, and the client’s sense of identity without proving that cannabis caused every later difficulty.

The adult assessment considers the longitudinal pattern and current needs. It does not provide pediatric or adolescent treatment unless that separate capability is formally established.

Cannabis and the Daily Routine

Use may become linked with waking, meals, exercise, creative work, social contact, or the transition to sleep. Removing the substance can reveal how little structure remains in the day and how strongly ordinary activities have become conditioned cues.

Residential treatment can help rebuild routines around sleep, food, movement, work, and relationships. The aim is not rigid scheduling for its own sake, but enough stability for the client to recognize choice and function without intoxication.

How Progress Is Reviewed

Progress may include reduced use, sustained abstinence where agreed, improved sleep after withdrawal, clearer cognition, less anxiety or paranoia, restored motivation, and better participation in work or relationships. A single symptom should not be used as the only measure.

Marijuana Addiction Treatment and Cannabis Rehab

Marijuana and cannabis refer to the same treatment topic here; separate service pages are not needed for each term. Rehabilitation should connect assessment of the use pattern with sleep, emotional health, everyday functioning and preparation for the return home. The linked understanding and withdrawal articles provide fuller educational explanations, while this page describes the role and limits of individual treatment.

Whether residential care is appropriate depends on the person’s needs, current risks and available support. A period without cannabis is not the entire plan. Treatment should also consider what has maintained use and how continuing care will support the situations the client will face after leaving the residence.

Explore This Topic

Understanding the condition Detox and withdrawal

Choosing the Best Private Cannabis Treatment for Your Needs

When comparing luxury rehab programs in Europe or worldwide, ask how cannabis use, sleep, mood, anxiety, medication, and other substances are assessed. Clarify addiction-specific work and continuing care. The best fit follows impaired control and clinical needs, not assumptions based only on frequency, legality, or medical authorization.

Private Cannabis Rehab in Switzerland and Spain

Zurich, Switzerland

Zurich may be relevant when private residential care and indicated external Swiss clinical support fit your needs and are available.

Mallorca, Spain

Mallorca offers a private base for individual treatment and practical work on the routines, relationships, and access patterns relevant after the stay.

Both use the one-client model. Suitability, treatment language, residence arrangements, services, and ongoing support are confirmed individually. Luxury describes the environment, not a guarantee of abstinence or recovery.

Questions

Frequently Asked Questions

Can cannabis use and other mental-health or sleep concerns be treated within one plan?

Yes. Relevant anxiety, depression, trauma, attention, sleep, pain, medication, and other substance use can inform a coordinated assessment. The plan identifies appropriate professionals and priorities. Multiple concerns do not automatically exclude care, but current risks and available capability determine the setting.

Does frequent cannabis use always mean addiction?

No. Diagnosis depends on impaired control, clinically significant harm, tolerance, withdrawal, and continued use despite consequences, not frequency alone.

Can cannabis cause withdrawal?

Frequent users may experience irritability, anxiety, sleep disturbance, vivid dreams, appetite change, low mood, restlessness, or craving after stopping.

Can cannabis cause psychosis?

Cannabis can be associated with paranoia and psychosis, particularly with high-potency or frequent use and individual vulnerability. Acute psychosis requires prompt psychiatric assessment.

What if cannabis was prescribed?

The medical indication, benefit, dose, product, risks, and alternatives should be reviewed with the responsible prescriber. Prescribed use does not automatically exclude dependence or side effects.

Is there a medication for cannabis use disorder?

There is no universal approved medication that resolves cannabis use disorder. Treatment is primarily psychological and behavioral, with symptom or co-occurring-condition medication considered individually.

Can sleep problems be treated at the same time?

Yes. Sleep is assessed in relation to cannabis, withdrawal, anxiety, pain, circadian rhythm, medication, and possible medical sleep disorders.

When is hospital care needed?

Acute psychosis, severe confusion, dangerous behavior, immediate suicide risk, or medical instability requires urgent local emergency or hospital care.

Where does treatment take place?

Residential treatment takes place in Mallorca or Zurich, one client per residence and program. London supports selected assessment and continuing-care functions only.

Editorial evidence

Evidence & sources

Selected clinical guidelines, peer-reviewed research, and public-health sources used in this article.

01CDC: Cannabis Use Disorder
02CDC: Cannabis and Mental Health
03SAMHSA: Marijuana and Cannabidiol
View all 4 sourcesShow fewer sources
04NICE CG51: Drug Misuse in Over 16s: Psychosocial Interventions
What this includes
01

Assessment

The situation is understood in context before recommendations are made.

02

Individual team

Disciplines and practitioners are selected around the presentation.

03

Continuity

Care considers family, home, and existing professional relationships.

Not sure where the situation fits?

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager

A confidential first conversation can help clarify the presentation and whether our setting is appropriate.

THE BALANCE
A PLACE TO BEGIN

Ask about our care